Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014 (2014), Article ID 276260, 14 pages
http://dx.doi.org/10.1155/2014/276260
Review Article

Carrier-Based Drug Delivery System for Treatment of Acne

University Institute of Pharmacy, Pandit Ravishankar Shukla University, Raipur 492 010, India

Received 31 August 2013; Accepted 25 December 2013; Published 9 February 2014

Academic Editors: H. Fujita and C. Schepis

Copyright © 2014 Amber Vyas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Ho, D. Schacter, and R. Miller, “Acne management for the 90s: current treatment guidelines,” The Canadian Journal of Diagnosis, vol. 12, pp. 1–25, 1995. View at Google Scholar
  2. M. K. Arora, A. Yadav, and V. Saini, “Role of hormones in acne vulgaris,” Clinical Biochemistry, vol. 44, no. 13, pp. 1035–1040, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Falcocchio, C. Ruiz, F. I. J. Pastor, L. Saso, and P. Diaz, “Propionibacterium acnes GehA lipase, an enzyme involved in acne development, can be successfully inhibited by defined natural substances,” Journal of Molecular Catalysis B, vol. 40, no. 3-4, pp. 132–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. D. F. Bloom, “Is acne really a disease? A theory of acne as an evolutionarily significant, high-order psychoneuroimmune interaction timed to cortical development with a crucial role in mate choice,” Medical Hypotheses, vol. 62, no. 3, pp. 462–469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. A. W. Lucky, S. I. Cullen, T. Funicella, M. T. Jarratt, T. Jones, and M. E. Reddick, “Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris,” Journal of the American Academy of Dermatology, vol. 38, no. 4, pp. S24–S30, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Jain and E. Basal, “Inhibition of Propionibacterium acnes-induced mediators of inflammation by Indian herbs,” Phytomedicine, vol. 10, no. 1, pp. 34–38, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Leyden and A. Kligman, “Acne vulgaris: new concepts in pathogenesis and treatment,” Drugs, vol. 12, no. 4, pp. 292–300, 1976. View at Google Scholar · View at Scopus
  8. E. Palombo-Kinne, I. Schellschmidt, U. Schumacher, and T. Gräser, “Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate,” Contraception, vol. 79, no. 4, pp. 282–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Yamaguchi, K. Satoh-Yamaguchi, and M. Ono, “In vitro evaluation of antibacterial, anticollagenase, and antioxidant activities of hop components (Humulus lupulus) addressing acne vulgaris,” Phytomedicine, vol. 16, no. 4, pp. 369–376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Leyden, A. Shalita, M. Hordinsky, L. Swinyer, F. Z. Stanczyk, and M. E. Weber, “Efficacy of a low-dose oral contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for the treatment of moderate acne: a randomized, placebo-controlled trial,” Journal of the American Academy of Dermatology, vol. 47, no. 3, pp. 399–409, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kawashima, S. Harada, C. Loesche, and Y. Miyachi, “Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study,” Journal of Dermatological Science, vol. 49, no. 3, pp. 241–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Huber and K. Walch, “Treating acne with oral contraceptives: use of lower doses,” Contraception, vol. 73, no. 1, pp. 23–29, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. M. Thiboutot, J. Weiss, A. Bucko et al., “Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study,” Journal of the American Academy of Dermatology, vol. 57, no. 5, pp. 791–799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Yang, D. Pornpattananangkul, T. Nakatsuji et al., “The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes,” Biomaterials, vol. 30, no. 30, pp. 6035–6040, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Mitchell and A. Dudley, Acne: The at Your Fingertips Guide, Class Publishing, 2002.
  16. J. Brieva, G. A. McCracken, and B. Diamond, “Update and treatment of acne vulgaris,” Medical Update for Psychiatrists, vol. 2, no. 6, pp. 161–163, 1997. View at Google Scholar · View at Scopus
  17. J. J. Leyden, “Topical treatment of acne vulgaris: retinoids and cutaneous irritation,” Journal of the American Academy of Dermatology, vol. 38, no. 4, pp. S1–S4, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Liao, “Management of acne,” Journal of Family Practice, vol. 52, no. 1, pp. 43–51, 2003. View at Google Scholar · View at Scopus
  19. A. Reich, B. Jasiuk, D. Samotij, A. Tracinska, K. Trybucka, and J. C. Szepietowski, “Acne vulgaris: what teenagers think about it,” Dermatology Nursing, vol. 19, no. 1, pp. 49–64, 2007. View at Google Scholar · View at Scopus
  20. G. M. White, “Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris,” Journal of the American Academy of Dermatology, vol. 39, no. 2, pp. S34–S37, 1998. View at Google Scholar · View at Scopus
  21. L. F. Eichenfield, J. F. Fowler Jr., R. G. Fried, S. F. Friedlander, M. L. Levy, and G. F. Webster, “Perspectives on therapeutic options for acne: an update,” Seminars in Cutaneous Medicine and Surgery, vol. 29, no. 2, pp. 13–16, 2010. View at Google Scholar · View at Scopus
  22. A. R. Shalita, “Acne: clinical presentations,” Clinics in Dermatology, vol. 22, no. 5, pp. 385–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Shaw and C. Kennedy, “The treatment of acne,” Current Paediatrics, vol. 13, no. 6, pp. 423–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Shaw and C. Kennedy, “The treatment of acne,” Paediatrics and Child Health, vol. 17, no. 10, pp. 385–389, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. H. Stein and M. Lebwohl, “Acne therapy: clinical pearls,” Seminars in Cutaneous Medicine and Surgery, vol. 20, no. 3, pp. 184–189, 2001. View at Google Scholar · View at Scopus
  26. H. Jones, D. Blanc, and W. J. Cunliffe, “Tretinoin (retinoic acid) in acne,” The Medical Letter on Drugs and Therapeutics, vol. 15, no. 1, article 3, 1973. View at Google Scholar
  27. H. Jones, D. Blanc, and W. J. Cunliffe, “13-cis retinoic acid and acne,” The Lancet, vol. 2, no. 8203, pp. 1048–1049, 1980. View at Google Scholar · View at Scopus
  28. A. Bérard, L. Azoulay, G. Koren, L. Blais, S. Perreault, and D. Oraichi, “Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective,” British Journal of Clinical Pharmacology, vol. 63, no. 2, pp. 196–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. S. C. Holmes, U. Bankowska, and R. M. Mackie, “The prescription of isotretinoin to women: is every precaution taken?” British Journal of Dermatology, vol. 138, no. 3, pp. 450–455, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. R. J. Hirsch and A. B. Lewis, “Treatment of acne scarring,” Seminars in Cutaneous Medicine and Surgery, vol. 20, no. 3, pp. 190–198, 2001. View at Google Scholar · View at Scopus
  31. A. Katsambas and A. Papakonstantinou, “Acne: systemic treatment,” Clinics in Dermatology, vol. 22, no. 5, pp. 412–418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. C. C. Zouboulis, “Acne and sebaceous gland function,” Clinics in Dermatology, vol. 22, no. 5, pp. 360–366, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Gollnick, W. Cunliffe, D. Berson et al., “Management of acne: a report from a global alliance to improve outcomes in acne,” Journal of the American Academy of Dermatology, vol. 49, no. 1, pp. S1–S2, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Gollnick and M. Schramm, “Topical drug treatment in acne,” Dermatology, vol. 196, no. 1, pp. 119–125, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Gollnick, “Current concepts of the pathogenesis of acne: implications for drug treatment,” Drugs, vol. 63, no. 15, pp. 1579–1596, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. J. J. Leyden, J. Q. del Rosso, and G. F. Webster, “Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance,” Cutis, vol. 79, no. 6, pp. 9–25, 2007. View at Google Scholar · View at Scopus
  37. C. N. Ellis, L. E. Millikan, E. B. Smith et al., “Comparison of adapalene 0-1% solution and tretinoin 0-025% gel in the topical treatment of acne vulgaris,” British Journal of Dermatology, vol. 139, no. 52, pp. 41–47, 1998. View at Google Scholar · View at Scopus
  38. A. Vogt, B. Combadiere, S. Hadam et al., “40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin,” Journal of Investigative Dermatology, vol. 126, no. 6, pp. 1316–1322, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Lademann, H. Richter, A. Teichmann et al., “Nanoparticles—an efficient carrier for drug delivery into the hair follicles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 2, pp. 159–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Rolland, N. Wagner, A. Chatelus, B. Shroot, and H. Schaefer, “Site-specific drug delivery to pilosebaceous structures using polymeric microspheres,” Pharmaceutical Research, vol. 10, no. 12, pp. 1738–1744, 1993. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Leydon, “Comparing facial tolerability of a 3-step acne system containing a novel solubilized 5% benzoyl peroxide lotion for normal to dry skin with that of a benzoyl peroxide/clindamycin combination prescription product,” Journal of the American Academy of Dermatology, vol. 58, supplement 2, no. 2, p. 15, 2008. View at Publisher · View at Google Scholar
  42. D. Thiboutot, M. Jarratt, P. Rich, T. Rist, D. Rodriguez, and S. Levy, “A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris,” Clinical Therapeutics, vol. 24, no. 5, pp. 773–785, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Wang, H. S. Kwak, N. Elbuluk et al., “Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne,” Journal of the American Academy of Dermatology, vol. 61, no. 2, pp. 252–258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Gabriëls, M. Brisaert, and J. Plaizier-Vercammen, “Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 48, no. 1, pp. 53–58, 1999. View at Publisher · View at Google Scholar · View at Scopus
  45. M. C. Spellman and S. H. Pincus, “Efficacy and safety of azelaic acid and glycolic acid combination therapy compared with tretinoin therapy for acne,” Clinical Therapeutics, vol. 20, no. 4, pp. 711–721, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Verschoore, M. Poncet, J. Czernielewski, V. Sorba, and A. Clucas, “Adapalene 0.1% gel has low skin-irritation potential,” Journal of the American Academy of Dermatology, vol. 36, no. 6, supplement, pp. S104–S109, 1997. View at Google Scholar · View at Scopus
  47. A. R. Shalita, D. S. Berson, D. M. Thiboutot et al., “Effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials,” Clinical Therapeutics, vol. 26, no. 11, pp. 1865–1873, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Xu, X. Yang, and X. Xu, “Preparation and evaluation of tea tree oil liposome,” West China Journal of Pharmaceutical Sciences, 2006. View at Google Scholar
  49. A. Rougier and A. Richard, “Efficacy and safety of a new salicylic acid derivative as a complement of vitamin A acid in acne treatment,” European Journal of Dermatology, vol. 12, no. 4, pp. 49–50, 2002. View at Google Scholar · View at Scopus
  50. A. Yaroshinsky and J. Leyden, “The safety and efficacy of clindamycin [1% as clindamycin phosphate and tretinoin (0. 025%)] for the treatment of acne vulgaris: a combined analysis of results from six controlled safety and efficacy trials,” European Journal of Dermatology, vol. 50, no. 3, p. 23, 2004. View at Google Scholar
  51. B. Vermeulen, J. P. Remon, and H. Nelis, “The formulation and stability of erythromycin-benzoyl peroxide in a topical gel,” International Journal of Pharmaceutics, vol. 178, no. 1, pp. 137–141, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. A. W. Lucky, J. M. Maloney, J. Roberts et al., “Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term treatment,” Journal of Drugs in Dermatology, vol. 6, no. 10, pp. 981–987, 2007. View at Google Scholar · View at Scopus
  53. J. Q. del Rosso, “The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris,” Journal of Clinical and Aesthetic Dermatology, vol. 2, no. 8, pp. 26–29, 2009. View at Google Scholar · View at Scopus
  54. G. A. Castro and A. M. Ferreira, “Novel vesicular and particulate drug delivery systems for topical treatment of acne,” Expert Opinion on Drug Delivery, vol. 5, no. 6, pp. 665–679, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. H. C. Korting and M. S. Korting, “Carriers in the topical treatment of skin disease,” Handbook of Experimental Pharmacology, vol. 197, pp. 435–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D. D. Breimer and R. Speiser, Topics in Pharmaceutical Sciences, Elsevier, New York, NY, USA, 1985.
  57. A. Ajazuddin and S. Saraf, “Applications of novel drug delivery system for herbal formulations,” Fitoterapia, vol. 81, no. 7, pp. 680–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. M. B. R. Pierre and I. D. S. M. Costa, “Liposomal systems as drug delivery vehicles for dermal and transdermal applications,” Archives of Dermatological Research, vol. 303, no. 9, pp. 607–621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Patel, “Liposome: a versatile platform for targeted delivery of drugs,” Pharmainfo.net, 2006.
  60. G. Maghraby, B. W. Barry, and A. C. Williams, “Liposomes and skin: from drug delivery to model membranes,” European Journal of Pharmaceutical Sciences, vol. 34, no. 4-5, pp. 203–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. T. M. Allen, I. Ahmad, D. E. Lopes de Menezes, and E. H. Moase, “Immunoliposome-mediated targeting of anti-cancer drugs in vivo,” Biochemical Society Transactions, vol. 23, no. 4, pp. 1073–1079, 1995. View at Google Scholar · View at Scopus
  62. J. Vyas, P. Vyas, D. Raval, and P. Paghdar, “Development of topical niosomal gel of benzoyl peroxide,” International Journal of Nanotechnology, vol. 2011, Article ID 503158, 6 pages, 2011. View at Publisher · View at Google Scholar
  63. M. Manconi, C. Sinico, D. Valenti, F. Lai, and A. M. Fadda, “Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin,” International Journal of Pharmaceutics, vol. 311, no. 1-2, pp. 11–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Fluhr, O. Barsom, W. Gehring, and M. Gloor, “Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes,” Dermatology, vol. 198, no. 3, pp. 273–277, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Honzak and M. Šentjurc, “Development of liposome encapsulated clindamycin for treatment of acne vulgaris,” European Journal of Physiology, vol. 440, no. 5, pp. R44–R45, 2000. View at Google Scholar · View at Scopus
  66. S. S. Bhalerao and A. R. Harshal, “Preparation, optimization, characterization, and stability studies of salicylic acid liposomes,” Drug Development and Industrial Pharmacy, vol. 29, no. 4, pp. 451–467, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. C. Sinico, M. Manconi, M. Peppi, F. Lai, D. Valenti, and A. M. Fadda, “Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction,” Journal of Controlled Release, vol. 103, no. 1, pp. 123–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. N. Kaur, R. Puri, and S. K. Jain, “Drug-cyclodextrin-vesicles dual carrier approach for skin targeting of anti-acne agent,” AAPS PharmSciTech, vol. 11, no. 2, pp. 528–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. S. M. Samani, H. Montaseri, and M. Jamshidnejad, “Preparation and evaluation of cyproterone acetate liposome for topical drug delivery,” Iranian Journal of Pharmaceutical Sciences, vol. 5, no. 4, pp. 199–204, 2009. View at Google Scholar
  70. R. Kumar, B. Singh, G. Bakshi, and O. P. Katare, “Development of liposomal systems of finasteride for topical applications: design, characterization, and in vitro evaluation,” Pharmaceutical Development and Technology, vol. 12, no. 6, pp. 591–601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Fadel, M. Salah, N. Samy, and M. Soliman, “Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris,” Journal of Drugs in Dermatology, vol. 8, no. 11, pp. 983–990, 2009. View at Google Scholar · View at Scopus
  72. V. Jigar, G. Vishal, G. Tejas, C. Vishal, and U. Umesh, “Formulation and characterization of topical gel of erythromycin entrapped into niosomes,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1714–1718, 2011. View at Google Scholar · View at Scopus
  73. M. Jelvehgari, M. R. Siahi-Shadbad, S. Azarmi, G. P. Martin, and A. Nokhodchi, “The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies,” International Journal of Pharmaceutics, vol. 308, no. 1-2, pp. 124–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. J. Desouza, “The microsponge drug delivery system: for delivering an active ingredient by controlled time release,” Pharmaifo.net, 2008.
  75. S. Khanna, O. P. Katre, and S. Drabhu, “Lecithinized microemulsion for topical delivery of tretionoin,” International Journal of Research in Drug Delivery, vol. 2, no. 4, pp. 711–719, 2010. View at Google Scholar
  76. A. M. Suthar, J. D. Modi, M. P. Patel, and A. H. Baria, “Microemulsion-based gel formulation and evaluation of tretinoin for topical delivery,” International Journal of Pharmaceutical Research, vol. 1, no. 4, pp. 28–34, 2009. View at Google Scholar
  77. M. Trotta, E. Ugazio, E. Peira, and C. Pulitano, “Influence of ion pairing on topical delivery of retinoic acid from microemulsions,” Journal of Controlled Release, vol. 86, no. 2-3, pp. 315–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Bikowski and J. Q. Del Rosso, “Case reports: benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne,” Journal of Drugs in Dermatology, vol. 7, no. 6, pp. 590–595, 2008. View at Google Scholar · View at Scopus
  79. R. Berger, R. Rizer, A. Barba et al., “Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial,” Clinical Therapeutics, vol. 29, no. 6, pp. 1086–1097, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. D. Rasool, E. Rahmani, and E. Forboad, “Gelatin microspheres for the controlled release of all-trans-retinoic acid topical formulation and drug delivery evaluation,” Iranian Journal of Pharmaceutical Research, pp. 47–50, 2003. View at Google Scholar
  81. S. D. Mandawgade and V. B. Patravale, “Development of SLNs from natural lipids: application to topical delivery of tretinoin,” International Journal of Pharmaceutics, vol. 363, no. 1-2, pp. 132–138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang, “Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery,” International Journal of Pharmaceutics, vol. 328, no. 2, pp. 191–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Czermak, T. Steinle, M. Ebrahimi, T. Schmidts, and F. Runkel, “Membrane-assisted production of S1P loaded SLNs for the treatment of acne vulgaris,” Desalination, vol. 250, no. 3, pp. 1132–1135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. J. Štecová, W. Mehnert, T. Blaschke et al., “Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake,” Pharmaceutical Research, vol. 24, no. 5, pp. 991–1000, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. C. L. Domínguez-Delgado, I. M. Rodríguez-Cruz, J. J. Escobar-Chávez, I. O. Calderón-Lojero, D. Quintanar-Guerrero, and A. Ganem, “Preparation and characterization of triclosan nanoparticles intended to be used for the treatment of acne,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 79, no. 1, pp. 102–107, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. T. W. Lee, J. C. Kim, and S. J. Hwang, “Hydrogel patches containing triclosan for acne treatment,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 56, no. 3, pp. 407–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Ascenso, F. Vultos, D. Ferrinho et al., “Effect of tretinoin inclusion in dimethyl-beta-cyclodextrins on release rate from a hydrogel formulation,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Gavini, V. Sanna, R. Sharma et al., “Solid lipid microparticles (SLM) containing juniper oil as anti-acne topical carriers: preliminary studies,” Pharmaceutical Development and Technology, vol. 10, no. 4, pp. 479–487, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Karthikeyan, “Non-ionic surfactant based vesicle “Niosome” as a potential ocular drug delivery system—an overview,” Pharmainfo.net, 2008.
  90. T. Sudhamani, N. Priyadarisini, and M. Radhakrishnan, “Proniosomes—a promising drug carriers,” International Journal of PharmTech Research, vol. 2, no. 2, pp. 1446–1454, 2010. View at Google Scholar · View at Scopus
  91. V. P. Devang and M. Misra, Niosome: A Magic Targeted Drug Delivery System, PharmaTutor Pharmacy Infopedia, 2011.
  92. A. Kumar, J. L. Pal, A. Jaiswal, and V. Singh, “Niosomes as novel drug delivery system,” International Research Journal of Pharmacy, vol. 2, no. 5, pp. 61–65, 2011. View at Google Scholar
  93. M. Manconi, C. Sinico, D. Valenti, G. Loy, and A. M. Fadda, “Niosomes as carriers for tretinoin. I. Preparation and properties,” International Journal of Pharmaceutics, vol. 234, no. 1-2, pp. 237–248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  94. J. D. Yadav, P. R. Kulkarni, K. A. Vaidya, and G. T. Shelke, “Niosomes: a review,” Journal of Pharmacy Research, vol. 4, no. 3, pp. 632–636, 2011. View at Google Scholar
  95. I. F. Uchegbu and S. P. Vyas, “Non-ionic surfactant based vesicles (niosomes) in drug delivery,” International Journal of Pharmaceutics, vol. 172, no. 1-2, pp. 33–70, 1998. View at Publisher · View at Google Scholar · View at Scopus
  96. A. J. Baillie, A. T. Florence, L. R. Hume, G. T. Muirhead, and A. Rogerson, “The preparation and properties of niosomes-non-ionic surfactant vesicles,” The Journal of Pharmacy and Pharmacology, vol. 37, no. 12, pp. 863–868, 1985. View at Google Scholar · View at Scopus
  97. S. P. Vyas and R. K. Khar, Targeted and Controlled Drug Delivery-Novel Carrier System, CBS Publication, 2002.
  98. L. Delattre and I. Delneuville, “Biopharmaceutical aspects of the formulation of dermatological vehicles,” Journal of the European Academy of Dermatology and Venereology, vol. 5, supplement 1, 70 pages, 1995. View at Google Scholar
  99. K. Embil and S. Nacht, “The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives,” Journal of Microencapsulation, vol. 13, no. 5, pp. 575–588, 1996. View at Google Scholar · View at Scopus
  100. S. Nacht and M. Katz, “The microsponge: a novel topical programmable delivery system,” in Topical Drug Delivery Formulations, D. W. Osborne and A. H. Amman, Eds., pp. 299–325, 1990. View at Google Scholar
  101. A. Pattani, S. Phadnis, and V. Patravale, “Microsponges: a path-breaking cosmetic innovation,” Household and Personal Care Today, vol. 2, pp. 45–49, 2008. View at Google Scholar
  102. C. Clarkson, V. J. Maharaj, and N. R. Crouch, “In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa,” Journal of Ethnopharmacology, vol. 92, no. 2-3, pp. 177–191, 2004. View at Google Scholar
  103. R. P. Bagwe, J. R. Kanicky, B. J. Palla, P. K. Patanjali, and D. O. Shah, “Improved drug delivery using microemulsions: rationale, recent progress, and new horizons,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 18, no. 1, pp. 77–140, 2001. View at Google Scholar · View at Scopus
  104. R. Andre and G. Pierard, “Efficacy and safety of a new salicylic acid derivative as a complement of vitamin a acid in acne treatment,” Journal of the American Academy of Dermatology, vol. 56, supplement 2, no. 2, p. 15, 2007. View at Publisher · View at Google Scholar
  105. M. R. Patel, “Microemulsions: as novel drug delivery vehicle,” Pharmainfo.net, 2007.
  106. I. A. Lee and H. I. Maibach, “Pharmionics in dermatology: a review of topical medication adherence,” The American Journal of Clinical Dermatology, vol. 7, no. 4, pp. 231–236, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. L. H. Kircik, “Microsphere technology: hype or help?” Journal of Clinical and Aesthetic Dermatology, vol. 4, no. 5, pp. 27–31, 2011. View at Google Scholar · View at Scopus
  108. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  109. A. Dingler and S. Gohla, “Production of solid lipid nanoparticles (SLN): scaling up feasibilities,” Journal of Microencapsulation, vol. 19, no. 1, pp. 11–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  110. S. A. Wissing, O. Kayser, and R. H. Müller, “Solid lipid nanoparticles for parenteral drug delivery,” Advanced Drug Delivery Reviews, vol. 56, no. 9, pp. 1257–1272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  111. W. Mehnert and K. Mader, “Solid lipid nanoparticles production, characterization and applications,” Advanced Drug Delivery Reviews, vol. 47, pp. 165–196, 2001. View at Google Scholar
  112. J. S. Patil, M. V. Kamalapur, S. C. Marapur, and D. V. Kadam, “Ionotropic gelation and polyelectrolyte complexation: the novel techniques to design hydrogel particulate sustained, modulated drug delivery system: a review,” Digest Journal of Nanomaterials and Biostructures, vol. 5, no. 1, pp. 241–248, 2010. View at Google Scholar · View at Scopus
  113. M. Taglietti, C. N. Hawkins, and J. Rao, “Novel topical drug delivery systems and their potential use in acne vulgaris,” Skin Therapy Letter, vol. 13, no. 5, pp. 6–8, 2008. View at Google Scholar · View at Scopus
  114. M. Jothish, N. P. Chodavarapu, P. Kundana, and G. S. C. Reddy, “Novel drug delivery system and its used in the treatment of acne,” International Journal of PharmTech, vol. 2, no. 1, pp. 41–53, 2010. View at Google Scholar
  115. V. Iannuccelli, N. Sala, R. Tursilli, G. Coppi, and S. Scalia, “Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 63, no. 2, pp. 140–145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  116. T. Rosanna and C. Alberto, “Enhancement of melatonin photo stability by encapsulation in lipospheres,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, pp. 255–262, 2006. View at Google Scholar
  117. B. Swansi, V. Gupta, and C. M. Prasad, “Formulation and evaluation of controlled release ibuprofen liposphere,” Journal of Natura Conscientia, vol. 15, pp. 363–374, 2011. View at Google Scholar
  118. M. Nasr, S. Mansour, N. D. Mortada, and A. A. El Shamy, “Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation,” AAPS PharmSciTech, vol. 9, no. 1, pp. 154–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  119. G. Fricker, T. Kromp, A. Wendel et al., “Phospholipids and lipid-based formulations in oral drug delivery,” Pharmaceutical Research, vol. 27, no. 8, pp. 1469–1486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Scalia, R. Tursilli, N. Sala, and V. Iannuccelli, “Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-β-cyclodextrin,” International Journal of Pharmaceutics, vol. 320, no. 1-2, pp. 79–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  121. M. Rawat and S. Saraf, “Lipospheres: emerging carriers in the delivery of proteins and peptides,” Internatinal Journal of Pharmaceutical Sciences and Nanotechnology, vol. 1, no. 3, pp. 207–214, 2008. View at Google Scholar
  122. M. Rawat, D. Singh, and S. Swarnlata, “Development and in vitro evaluation of polar lipid based lipospheres for oral delivery of peptide drugs,” International Journal of Drug Delivery, vol. 1, no. 1, pp. 15–26, 2011. View at Publisher · View at Google Scholar · View at Scopus
  123. T. Nakatsuji, L. Rasochova, and C. M. Huang, “Vaccine therapy for P. acnes-associated diseases,” Infectious Disorders, vol. 8, no. 3, pp. 160–165, 2008. View at Google Scholar · View at Scopus
  124. D. Mackenzie, In Development: A vaccine for Acne, New Scientist Health, 2011.
  125. A. Vyas and S. Saraf, “Cyclodextrin based novel drug delivery systems,” Journal of Inclusion Phenomena and Macrocyclic Chemistry, vol. 62, no. 1-2, pp. 23–42, 2008. View at Publisher · View at Google Scholar · View at Scopus